Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...
A recent breakthrough in medical research offers exciting possibilities for people dealing with diabetes and obesity. This ...
Irish Independent on MSN7h
Patients taking weight-loss jabs at clinic had ‘significant reduction’ in alcohol intake, study showsHeavy drinkers who were taking weight-loss jabs in a Dublin clinic significantly reduced their alcohol intake down from 12 ...
In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...
In its Citizen Petition to the FDA, Novo Nordisk argued that there is no clinical need to allow compounding for liraglutide, ...
The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...
(HealthDay News) — The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), a glucagon-like peptide-1 (GLP-1) receptor agonist ...
Novo Nordisk petitions the FDA to exclude liraglutide from the 503B Bulks List, citing safety risks, lack of clinical need, ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback